Ebola outbreaks killing thousands of gorillas and chimpanzeesApril 17, 2007Vaccination may work to stop the outbreaks Why have large outbreaks of Ebola virus killed tens of thousands of gorillas and chimpanzees over the last decade? Observations published in the May issue of The American Naturalist provide new clues, suggesting that outbreaks may be amplified by Ebola transmission between ape social groups. The study provides hope that newly developed vaccines could control the devastating impact of Ebola on wild apes. Direct encounters between gorilla or chimpanzee social groups are rare. Therefore, when reports of large ape die-offs first surfaced in the late 1990s, outbreak amplification was assumed to be through "massive spillover" from some unknown reservoir host. The new study, conducted by researchers from the Max Planck Institute for Evolutionary Anthropology, Cambridge University, and Stony Brook University at three sites in northern Republic of Congo, suggests that Ebola transmission between ape groups might occur through routes other than direct social encounter. For instance, as many as four different gorilla groups fed in the same fruit tree on a single day. Thus, infective body fluids deposited by one group might easily be encountered by a subsequent group. Chimpanzees and gorillas also fed simultaneously in the same fruit tree at least once every seven days. The study also provided the first evidence that gorillas from one social group closely inspect the carcasses of gorillas from other groups. Contact with corpses at funerals is a major mechanism of Ebola transmission in humans. Together with other recent observations on patterns of gorilla mortality, these results make a strong case that transmission between ape social groups plays a central role in Ebola outbreak amplification. The study has important implications for controlling the impact of Ebola, which has killed roughly one quarter of the world gorilla population. "It means that vaccinating one gorilla does not protect only that gorilla, it also protects gorillas further down the transmission chain," said Peter Walsh of the Max Planck Institute for Evolutionary Anthropology, the lead author on the study. "Thus, protecting remaining ape populations may not require vaccinating a high proportion of individuals, as many people naively assume." Walsh and collaborators are currently searching for funding to implement a vaccination program using one of the several vaccines that have now successfully protected laboratory monkeys from Ebola. University of Chicago Press Journals |
|||||||||||||||||||||
| Related Ebola Current Events and Ebola News Articles 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan. Outfoxing pox: Developing a new class of vaccine candidates In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox. World will miss 2010 target to stem biodiversity loss, experts say The world will miss its agreed target to stem biodiversity loss by next year, according to experts convening in Cape Town for a landmark conference devoted to biodiversity science. Scientists block Ebola infection in cell-culture experiments Researchers at the University of Texas Medical Branch at Galveston have discovered two biochemical pathways that the Ebola virus relies on to infect cells. OHSU scientists partner with others to form center aimed at combating infectious diseases Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health. Drug blocks 2 of world's deadliest emerging viruses Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. Penn Study Identifies How Ebola Virus Avoids the Immune System Researchers at the University of Pennsylvania School of Medicine have likely found one reason why the Ebola virus is such a powerful, deadly, and effective virus. Using a cell culture model for Ebola virus infection, they have discovered that the virus disables a cellular protein called tetherin that normally can block the spread of virus from cell to cell. Iowa State University researchers discover structure of key Ebola protein Research led by Iowa State University scientists has them a step closer to finding a way to counter the Ebola virus. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. More Ebola Current Events and Ebola News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||